These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 7835802)
21. Expanding the public health research agenda for ovarian cancer. Trivers KF; Stewart SL; Peipins L; Rim SH; White MC J Womens Health (Larchmt); 2009 Sep; 18(9):1299-305. PubMed ID: 19702475 [TBL] [Abstract][Full Text] [Related]
22. [New advances in screening and treatment of ovarian cancer]. Morice P; Pautier P; Bidart JM Bull Cancer; 2003 Jan; 90(1):53-60. PubMed ID: 12609805 [TBL] [Abstract][Full Text] [Related]
23. Making decisions about screening for ovarian cancer. Mass screening may not prove to be sound public health policy. Bell R BMJ; 2000 Apr; 320(7239):940; author reply 940-1. PubMed ID: 10787261 [No Abstract] [Full Text] [Related]
24. Gene therapy for ovarian cancer (review). Wolf JK; Jenkins AD Int J Oncol; 2002 Sep; 21(3):461-8. PubMed ID: 12168087 [TBL] [Abstract][Full Text] [Related]
25. Family physicians' perspectives on ovarian cancer. Gray RE; Chart P; Carroll JC; Fitch MI; Cloutier-Fisher D Cancer Prev Control; 1999 Feb; 3(1):61-7. PubMed ID: 10474754 [TBL] [Abstract][Full Text] [Related]
26. The role of a cancer risk assessment clinic. Med Manag Netw; 1999 Jul; 7(7):6-10. PubMed ID: 10538699 [No Abstract] [Full Text] [Related]
27. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines. Beckmann MW; Schnürch HG; Bodden-Heidrich R; Mosny DS; Crombach G; Nitz U; Achnoula M; Bender HG Eur J Cancer Prev; 1996 Dec; 5(6):468-75. PubMed ID: 9061278 [TBL] [Abstract][Full Text] [Related]
28. Screening for ovarian cancer: recommendations and rationale. American College of Physicians. Ann Intern Med; 1994 Jul; 121(2):141-2. PubMed ID: 8017728 [No Abstract] [Full Text] [Related]
29. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771 [TBL] [Abstract][Full Text] [Related]
33. Screening for ovarian cancer: not worthwhile for most patients. Wong JG; Feussner JR N C Med J; 1993 Sep; 54(9):438-40. PubMed ID: 8232615 [No Abstract] [Full Text] [Related]
34. [Problems in the organization of an anticancer campaign among women working for the October Railroad]. Ugriumova RP Vopr Onkol; 1966 Apr; 12(4):87-90. PubMed ID: 6001006 [No Abstract] [Full Text] [Related]
35. 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration. Stuart G; Avall-Lundqvist E; du Bois A; Bookman M; Bowtell D; Brady M; Casado A; Cervantes A; Eisenhauer E; Friedlaender M; Fujiwara K; Grenman S; Guastalla JP; Harper P; Hogberg T; Kaye S; Kitchener H; Kristensen G; Mannel R; Meier W; Miller B; Oza A; Ozols R; Parmar M; Pfisterer J; Poveda A; Provencher D; Pujade-Lauraine E; Quinn M; Randall M; Rochon J; Rustin G; Sagae S; Stehman F; Trimble E; Thigpen T; Vasey P; Vergote I; Verheijen R; Vermorken J; Wagner U; ; ; ; ; ; ; ; ; ; ; ; ; Ann Oncol; 2005; 16 Suppl 8():viii36-viii38. PubMed ID: 16239235 [No Abstract] [Full Text] [Related]